F a standardized protocol for prevention and management of oral mucositis in sufferers undergoing hematopoietic cell transplantation. J Oncol Pharm Pract 2010, 16:195?04. 14. Wu JC, Beale KK, Ma JD: Evaluation of current and upcoming therapies in oral mucositis prevention. Future Oncol 2010, 6:1751?770. 15. Banerjee SK, McGaffin KR, Pastor-Soler NM, Ahmad F: SGLT1 is usually a novel cardiac glucose transporter which is perturbed in disease states. Cardiovasc Res 2009, 84:111?18. 16. Ikari A, Nagatani Y, Tsukimoto M, Harada H, Miwa M: Sodium-dependent glucose transporter reduces peroxynitrite and cell injury caused by cisplatin in renal tubular epithelial cells. Biochim Biophys Acta 2005, 1717:109?17. 17. Gorboulev V, Sch mann A, Vallon V, Kipp H, Jaschke A, et al: Na(+)-Dglucose cotransporter SGLT1 is pivotal for intestinal glucose absorption and glucose-dependent incretin secretion. Diabetes 2012, 61:187?96. 18. Ikari A, Nakano M, Suketa Y, Harada H, Takagi K: Reorganization of ZO-1 by sodium-dependent glucose transporter activation following heat tension in LLC-PK1 cells. J Cell Physiol 2005, 203:471?78. 19. Palazzo M, Gariboldi S, Zanobbio L, Selleri S, Dusio GF, et al: Sodiumdependent glucose transporter-1 as a novel immunological player inside the intestinal mucosa. J Immunol 181:3126-3136 Erratum in. J Immunol 2008, 181:7428. 20. Yu LC, Flynn AN, Turner JR, Buret AG: SGLT-1-mediated glucose uptake protects intestinal epithelial cells against LPS-induced apoptosis and barrier defects: a novel cellular rescue mechanism? FASEB J 2005, 19:1822?823. 21. La Ferla B, Spinosa V, D’Orazio G, Palazzo M, Balsari A, et al: Dansyl C-glucoside as a novel agent against endotoxic shock. Chem Med Chem 2010, five:1677?680.Buy(1-Methylcyclopentyl)methanol 22.1130365-33-1 manufacturer Dekaney CM, Gulati AS, Garrison AP, Helmrath MA, Henning SJ: Regeneration of intestinal stem/progenitor cells following doxorubicin remedy of mice.PMID:23554582 Am J Physiol Gastrointest Liver Physiol 2009, 297:G461?0. 23. Liu L, Rao JN, Zou T, Xiao L, Smith A, Zhuang R, et al: Activation of Wnt3a signaling stimulates intestinal epithelial repair by advertising c-Myc-regulated gene expression. Am J Physiol Cell Physiol 2012, 302:C277 285. 24. K l SJ, K l M: Around the part of Wnt/-catenin signaling in stem cells. Biochim Biophys Acta 2013, 1830:2297?306. 25. De Koning BA, Lindenbergh-Kortleve DJ, Pieters R, B ler HA, Renes IB: Alterations in epithelial and mesenchymal intestinal gene expression for the duration of doxorubicin-induced mucositis in mice. Dig Dis Sci 2007, 52:1814?825. 26. Pellegrinet L, Rodilla V, Liu Z, Chen S, Koch U, et al: Dll1- and dll4-mediated notch signaling are expected for homeostasis of intestinal stem cells. Gastroenterology 2012, 140:1230?240.Cardani et al. Molecular Cancer 2014, 13:23 http://molecular-cancer/content/13/1/Page 12 of27. Beck PL, Wong JF, Li Y, Swaminathan S, Xavier RJ, et al: Chemotherapy- and radiotherapy-induced intestinal damage is regulated by intestinal trefoil element. Gastroenterology 2004, 126:796?08. 28. Bruininx EM, Koninkx JF, Binnendijk GP, Zandstra T, Heetkamp MJ, et al: Effects of prefermented cereals or the finish goods of fermentation on development and metabolism of enterocyte-like Caco-2 cells and on intestinal overall health of restrictedly fed weanling pigs. Animal 2010, four:40?1. 29. Kaczmarek A, Brinkman BM, Heyndrickx L, Vandenabeele P, Krysko DV: Severity of doxorubicin-induced modest intestinal mucositis is regulated by the TLR-2 and TLR-9 pathways. J Pathol 2012, 226:598?08. 30. Han X, Wu Z, Di J, Pan Y, Zhang H, et al: CXC.